Disclosure Panels Details Page
B-Cell Lymphomas Panel - Disclosures as of 09/23/2019
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Jeremy Abramson MD, MMSc | Celgene Corporation Juno Therapeutics, Inc. Seattle Genetics, Inc. |
AbbVie, Inc. Celgene Corporation EMD Serono Genentech, Inc. Janssen Pharmaceutica Products, LP Kite Pharma Roche Laboratories, Inc. |
None | None | ✔ |
| Ranjana Advani MD | Agensys Celgene Forty Seven Genentech/Roche Genetech/Roche Janssen Pharmaceutical Kura Merck Millenium Pharmacyclics Regeneron Sanofi Seattle Genetics |
AstraZeneca Pharmaceuticals LP Bayer HealthCare Cell Medica Genentech/Roche Gilead Kite Pharma Kyowa Seattle Genetics Takeda |
None | None | - |
| Nancy Bartlett MD | ADC Therapeutics Affimed Autolus Bristol Myers Squibb Celgene Corporation Forty Seven, Inc. Genentech, Inc. Immune Design Janssen Pharmaceutica Products, LP Kite Pharma Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Pharmacyclics Seattle Genetics, Inc. |
ADC Therapeutics | None | None | ✔ |
| Paolo Caimi MD | ADC Therapeutics Genentech, Inc. Millennium Pharmaceuticals, Inc. OncoTartis Rhizen Pharmaceuticals Roche Laboratories, Inc. TG Therapeutics |
Fate Therapeutics Genentech, Inc. Kite Pharma |
Celgene Corporation | None | ✔ |
| Julie Chang MD | None | None | None | None | ✔ |
| Julio Chavez MD | Bayer HealthCare Celgene Corporation Genentech, Inc. Karyopharm Therapeutics Kite Pharma Novartis Pharmaceuticals Corporation |
None | Janssen Pharmaceutica Products, LP | None | ✔ |
| Beth Christian MD | Acerta Pharma Celgene Corporation Cephalon, Inc. Genentech, Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. Millennium Pharmaceuticals, Inc. MorphoSys AG Seattle Genetics, Inc. Triphase |
Genentech, Inc. Seattle Genetics, Inc. |
None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Bita Fakhri MD | None | None | None | None | ✔ |
| Luis Fayad MD | None | None | None | None | - |
| Martha Glenn MD | Genentech, Inc. | None | None | None | ✔ |
| Leo Gordon MD | Zylem (nanoparticle research) | Takeda Pharmaceuticals North America, Inc. | Bayer HealthCare Gilead Sciences, Inc. Juno Therapeutics, Inc. |
None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Thomas Habermann MD | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Laura Hanisch PsyD | None | None | None | None | - |
| Francisco Hernandez-Ilizaliturri MD | None | Celgene Corporation Karyopharm Therapeutics Kite Pharma Seattle Genetics |
Pharmacyclics | None | ✔ |
| Mark Kaminski MD | None | Nordic Nanovector | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | ✔ |
| Christopher Kelsey MD | Duke University Medical Center | None | None | None | ✔ |
| Nadia Khan MD | Bristol Myers Squibb | Seattle Genetics, Inc. | Genentech, Inc. | None | - |
| Susan Krivacic MPAff | None | None | None | None | ✔ |
| Ann LaCasce MD, MMSc | None | Bristol Myers Squibb Seattle Genetics, Inc. |
Research to Practice | None | ✔ |
| Amitkumar Mehta MD | ADC Therapeutics Affimed ASTEX Celgene Corporation Forty Seven, Inc. Genentech, Inc. Gilead Sciences, Inc. Incyte Corporation Juno Therapeutics, Inc. Kite Pharma Pharmacyclics Rhizen Seattle Genetics, Inc. Takeda Pharmaceuticals North America, Inc. |
None | AstraZeneca Pharmaceuticals LP Celgene Corporation Kite Pharmaceuticals Kyowa Hakko Kirin Co., Ltd. Seattle Genetics, Inc. Spectrum Pharmaceuticals, Inc. |
None | ✔ |
| Auayporn Nademanee MD | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Rachel Rabinovitch MD | None | None | None | None | ✔ |
| Nishitha Reddy MD | None | AbbVie, Inc. Bayer HealthCare Bristol Myers Squibb Celgene Corporation Genentech, Inc. |
Celgene Corporation | None | ✔ |
| Erin Reid MD | AbbVie, Inc. ADC Therapeutics Aptose Biosciences Millennium Pharmaceuticals, Inc. Xencor |
None | None | None | ✔ |
| Kenneth Roberts MD | None | None | None | None | ✔ |
| Stephen Smith MD | Acerta Pharma AstraZeneca Pharmaceuticals LP DeNovo Biopharma Genentech, Inc. Incyte Corporation Merck & Co., Inc. Portola Pharmaceuticals, Inc. Seattle Genetics, Inc. |
AstraZeneca Pharmaceuticals LP | None | None | - |
| Hema Sundar PhD | None | None | None | None | ✔ |
| Bettyanne Sunderland BSN, OCN | None | None | None | None | - |
| Jakub Svoboda MD | Bristol Myers Squibb Celgene Corporation Incyte Corporation Merck & Co., Inc. Pharmacyclics Regeneron Pharmaceuticals, Inc. Seattle Genetics, Inc. TG Therapeutics |
AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Seattle Genetics, Inc. |
None | None | ✔ |
| Lode Swinnen MBChB | AbbVie, Inc. | Pharmacyclics | None | Johns Hopkins University | ✔ |
| Julie Vose MD, MBA | None | AbbVie, Inc. Acerta Pharma Epizyme Janssen Pharmaceutica Products, LP Karyopharm Therapeutics Kite Pharma Novartis Pharmaceuticals Corporation Seattle Genetics, Inc. vaniam group |
Verastem | None | - |
| Andrew Zelenetz MD, PhD | None | Adaptive Biotechnology Amgen Inc. AstraZeneca Pharmaceuticals LP Celgene Corporation Genentech, Inc. Gilead Hoffman La Roche MEI Pharma MorphoSys AG Novartis Pharmaceuticals Corporation Pfizer Inc. Pharmacyclics Roche Laboratories, Inc. Versatem |
None | None | ✔ |